Du Kuo, Ramachandran Anup, McGill Mitchell R, Mansouri Abdellah, Asselah Tarik, Farhood Anwar, Woolbright Benjamin L, Ding Wen-Xing, Jaeschke Hartmut
Department of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.
Hepatology Department, Beaujon Hospital, AP-HP, Clichy, France; INSERM U1149, Centre de Recherche sur l'Inflammation, Université Denis Diderot, PRES Paris Sorbonne Cité, Paris, France.
Food Chem Toxicol. 2017 Oct;108(Pt A):339-350. doi: 10.1016/j.fct.2017.08.020. Epub 2017 Aug 18.
Mitochondrial biogenesis (MB) is an adaptive response to maintain metabolic homeostasis after mitochondrial dysfunction. Induction of MB during APAP hepatotoxicity has not been studied. To investigate this, mice were treated with toxic doses of APAP and euthanized between 0 and 96 h. At early time points, APAP caused both mitochondrial dysfunction and reduction of mitochondrial mass, indicated by reduced activity of electron transport chain (ETC) complexes I and IV and depletion of mitochondrial DNA (mtDNA), respectively. Both ETC activity and mtDNA gradually recovered after 12 h, suggesting that MB occurs at late time points after APAP overdose. Immunofluorescent staining of mitochondria with mitochondrial outer membrane protein Tom20 further demonstrated that MB occurs selectively in hepatocytes surrounding necrotic areas. MB signaling mediators including PPARγ co-activator 1-α (Pgc-1α), nuclear respiratory factor-1 (Nrf-1) and mitochondrial fission protein dynamin-related protein-1 (Drp-1) were induced. Pgc-1α was selectively increased in hepatocytes surrounding necrotic areas. In addition, the time course of MB induction coincides with increased liver regeneration. Post-treatment with the known MB inducer SRT1720 increased Pgc-1α expression and liver regeneration, resulting in protection against late liver injury after APAP overdose. Thus, induction of MB is an important feature during APAP hepatotoxicity and liver regeneration.
线粒体生物合成(MB)是一种适应性反应,用于在线粒体功能障碍后维持代谢稳态。对乙酰氨基酚(APAP)肝毒性期间MB的诱导尚未得到研究。为了对此进行研究,给小鼠注射毒性剂量的APAP,并在0至96小时之间实施安乐死。在早期时间点,APAP导致线粒体功能障碍和线粒体质量减少,分别表现为电子传递链(ETC)复合体I和IV的活性降低以及线粒体DNA(mtDNA)的耗竭。12小时后,ETC活性和mtDNA均逐渐恢复,这表明MB发生在APAP过量后的晚期时间点。用线粒体外膜蛋白Tom20对线粒体进行免疫荧光染色进一步证明,MB选择性地发生在坏死区域周围的肝细胞中。包括过氧化物酶体增殖物激活受体γ共激活因子1-α(Pgc-1α)、核呼吸因子-1(Nrf-1)和线粒体分裂蛋白动力相关蛋白-1(Drp-1)在内的MB信号介质被诱导。Pgc-1α在坏死区域周围的肝细胞中选择性增加。此外,MB诱导的时间进程与肝脏再生增加相吻合。用已知的MB诱导剂SRT1720进行治疗后,Pgc-1α表达和肝脏再生增加,从而防止APAP过量后晚期肝损伤。因此,MB的诱导是APAP肝毒性和肝脏再生过程中的一个重要特征。